WASHINGTON—As patients increasingly turn to commercially available food sensitivity and microbiome tests in search of answers for their digestive symptoms, gastroenterologists find themselves navigating a landscape fraught with scientific uncertainty and marketing hype. At DDW 2024, experts shed light on the current state of diagnostic tools for disorders of gut–brain interaction, revealing a stark disconnect between their widespread use and the lack of evidence supporting their
NOVEMBER 13, 2024